Interpreting Post‐Discontinuation Trajectories After Semaglutide or Tirzepatide

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-03-23
DOI
https://doi.org/10.1111/dom.70710
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interpreting Post‐Discontinuation Trajectories After Semaglutide or Tirzepatide

Diabetes Obesity and Metabolism
Diabetes Treatment and Management
article

Interpreting Post‐Discontinuation Trajectories After Semaglutide or Tirzepatide

article en

Abstract

No abstract available for this paper.
Diabetes Obesity and Metabolism
Openalex Percentile: Top 13%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Interpreting Post‐Discontinuation Trajectories After Semaglutide or Tirzepatide · Diabetes Obesity and Metabolism (2026) | TGRS Research Map | TGRS